1 / 28

THE BASICS OF ASICS

THE BASICS OF ASICS. Dr. P.M. van Zyl Department of Pharmacology UFS 4 th June 2010. NSAIDS. Anti-inflammatory. Anti-pyretic. Analgesic. TWO WILD ASSUMPTIONS. NSAIDs cause analgesia via elimination of inflammation. COX-1 and -2 inhibition only mechanism of action. OBSERVATION.

catrin
Télécharger la présentation

THE BASICS OF ASICS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. THE BASICS OF ASICS Dr. P.M. van Zyl Department of Pharmacology UFS 4th June 2010

  2. NSAIDS Anti-inflammatory Anti-pyretic Analgesic

  3. TWO WILD ASSUMPTIONS • NSAIDs cause analgesia via elimination of inflammation. • COX-1 and -2 inhibition only mechanism of action.

  4. OBSERVATION • NSAIDs reduces cutaneous and corneal pain induced by acidic pH in absence of inflammation.

  5. THE TRUTH IS • Analgesic effects of NSAIDs are not necessarily consequence of anti-inflammatory action

  6. Known Analgesic Mechanisms on NSAIDs • Inhibition of inflammatory mediator release from neutrophils • Central neuromodulatory effect • ?Via NMDA receptors Nitric Oxide release PG release • Inhibition of acid-sensing ion channels (ASICs)

  7. Acidosis and Pain • Stable pH critical for normal cellular function. • Physiologic pH (extracellular: 7.3, intracellular: 7.0) • Tissue acidosis occurs in acute and chronic pain conditions: • Inflammation:extracellular pH (< pH=6) • Angina • Stroke • Ischaemic heart disease • Arthritis • Cancer • Trauma • Infection, hematomas and exercise. • Maintaining pH critical for neuronal functioning • Mild acidosisexcitatory injury of neurons because of proton inhibition of NMDA channels. • Severe acidosisneuronal injury.

  8. Acid Sensing • Elaborate pH surveillance system: Various types of acid sensors activated under various conditions INCLUDE: • Acid-sensing ion channels (ASICs): moderate  in extracellular pH • Transient receptor potential vanilloid-1 (TRPV1) ion channels: severe acidosis pH < 6. • Two-pore-domain K(+) (K(2P)) channels: small deviations in pH. • Expressed by primary sensory neurons •  acid sensing, acid-induced pain and acid-evoked feedback regulation of homeostatic reactions. • Upregulation and overactivity of acid sensors contribute to chronic pain

  9. ASICs • Best studied class of pH-detecting receptors. • H+-gated subgroup of degenerin/epithelial Na+ channel (DEG/ENaC) family of cation channels sensitive to amiloride*. • Preferentially permeable to Na+, to a lesser extent also conduct other cations (Ca2+, K+, Li+ and H+).

  10. ASICs • Expressed principally in NOCICEPTIVE sensory neurons • Able to induce action potential triggering on sensory neurons after moderate  extracellular pH. • Proton-gating of ASICs activate nociceptive sensory neurons depolarizing currents Significant source of pain and hyperalgesia.

  11. Inflammation and ASICs • Inflammatory mediators enhance ASIC activity and expression • Transcriptional induction and post-translational regulation of ASICs: participate in hypersensitization of nociceptive system.

  12. ASIC Isoforms Permeable to Na+ and Ca2+. No Ca2+ permeability. Dorsal Root Ganglia Pituitary

  13. ISOFORMS OF ASIC CHANNELS • ASIC1 (1a/1b) and ASIC3 widely distributed in primary sensory neurons: attractive targets for pain treatment. • ASIC3 and ASIC1a activated in acidity range pH 7,0 – 6,0, seen in several acute and chronic pain conditions. • ASIC3 • senses lactic acidosis  anaerobic metabolism: important in cardiac, muscle ischaemia. • contributes to hyperalgesia and allodynia in inflammation • more widely distributed in humans than in mice, ?more extensive role in human nociception.

  14. ASIC in Peripheral Nervous System • Dorsal root ganglion and trigeminal ganglion; subunit composition varies among DRG neurons of different sizes. • Neurons innervating skin, heart, gut and muscle. Detected in the eye, ear, taste buds and bone. • Localization characterized most thoroughly: ASIC2 and ASIC3 in specialized cutaneousnerve endings.

  15. The physiological significance of ASICs in the PNS • Location and properties make ASIC subunits attractive candidates to serve as H+-gated nociceptors. • Acidosis activate nociceptors and produce pain that can be attenuated by DEG/ENaC inhibitor amiloride. • Inflammatory mediators such as nerve growth factor (NGF), 5-hydroxytryptamine (5-HT or serotonin), interleukin- 1, bradykinin and brain-derived neurotrophic factor (BDNF) can stimulate ASIC transcription, ? contributes to pain-enhancing effects of these mediators.

  16. ASICs in the CNS • ASIC1a is the predominant functional ASIC subunit in CNS neurons. • Important role in • Ischaemic brain injury • Epilepsy • ?Fear-related conditions • ?Learning

  17. ASIC1a activation in acidosis-mediated and ischemic neuronal injury • Ischemia  anaerobic glycolysis lactic acid accumulation acidosis. • Severe cerebral ischemia: pH may drop to 6.3 and belowimportant role in ischemic brain injury. • Ca2+ overload causes toxicity in the ischemic brain, ASIC1a homomultimers conduct Ca2+: ASIC1a activation could contribute to cell damage and death in cerebral ischemia.

  18. Evidence for relevance to Ischemic stroke • Neurons lacking ASIC1a and cells treated with amiloride or PcTX-1 resisted acidosis-induced injury. • PcTX-1  effects of NMDA-induced cell death. • Disrupting ASIC1a reduced infarct volume by 60% in a mouse model of cerebral infarction. • ASIC1a blockade protectsup to 5hr, persists for 7+ days. • Intracerebroventricular NaHCO3 also protective. • NMDA + ASIC blockade  additional neuroprotection, prolongs effectiveness of NMDA blockade.

  19. ASIC1a activation in ischemic neuronal injury and neuroprotection by ASIC1a blocker.

  20. ASIC activation and epileptic seizure activity • Significant  brain pH during intense neuronal excitation or seizure activity • ASIC blockade by amiloride and selective ASIC1a blocker PcTX1 significantly inhibits increase of neuronal firing and neuronal damage caused by noxious stimuli. • = activation of ASIC1a channels involved in generation or maintenance of seizure activity and resultant seizure-mediated neuronal injury.

  21. Function of ASIC1a • Loss of ASIC1a •  disrupt hippocampal-dependent LTP and spatial memory (modest effect) • considerably impair cerebellum-dependent learning

  22. Function of ASIC1a • Substantial expression in amygdala: important in fear-related behavior. • Mice with a disruption of the gene encoding ASIC1a: fear response • Implication: risk-taking behavior (personality trait might be associated with loss of ASIC1a function.)

  23. Function of ASIC1a • Over-expressing ASIC1a in amygdala and elsewhere in the brainH+- evoked currents and enhanced context fear conditioning. • Implication: • provide animal model of acquired anxiety • ? prone to fearful behavior, • ? Also supersensitive to acidosis.: • ?Explain why many pts with panic disorder have panic attacks when breathing CO2. (that lowers brain pH).

  24. Pharmacological Modulation of ASICs: Amiloride • Diuretic block Na+/H+, Na+/ Ca2+ exchangers and ENaC • Non-specific reversible blocker for ASICs. • Inhibits acid-induced increase of [Ca2+]i and membrane depolarization. • Peripheral sensory system: acid-induced pain • CNS:  acid-mediated and ischemic neuronal injury. • Problems: • Nonspecificity for various ion channels and ion exchange systems • Na+/Ca2+ exchanger critical for maintaining cellular Ca2+ homeostasis and the survival of neurons against delayed calcium deregulation and injury caused by glutamate receptor activation. • NOT a future analgesic or neuroprotective agent in humans.

  25. Pharmacological Modulation of ASICs: • A-317567: non-selective ASIC blocker, 10-fold potency of amiloride, no diuresis or nutriuretic effect. Neuroprotection unknown • Psalmotoxin 1 (PcTX1) specifically inhibits ASIC1a current. Gating modulater, Neuroprotective, yet not practical • APETx2: inhibits ASIC3, fails to cover sustained currents

  26. NSAIDs • Various NSAIDs inhibit ASICs at therapeutic doses for analgesic effects. • Ibuprofen and flurbiprofen inhibit ASIC1a. • Aspirin, salicylate and diclofenac inhibit ASIC3. • Ideal for a large spectrum of pain conditions, particularly pain caused by tissue inflammation. • In acute phase of tissue inflammation: rapid inhibition of ASIC currents by NSAIDs blocks activation of pain-sensing neurons by inflammatory acidosis. • Later, NSAIDs suppress inflammation and pain via effect on COXs, limiting the production of PGs. • In chronic phase: reduce sensitization to pain by combined inhibition of COXs, ASIC currents, and ASIC expression.

  27. Concluding remarks • ASICs a novel target for intervention in acute and chronic pain • Ca2+-permeable ASIC1a a novel pharmacological target for ischemic brain injury. • NSAIDs worthy analgesics, on their own and as adjuvants.

  28. References • Wemmie, J.A., Price M.P. and Welsh, M. J. 2006. Acid-sensing ion channels: advances, questions and therapeutic opportunities TRENDS in Neurosciences 29(10). • Odendaal CL. 2010 Refresher Course: Are NSAIDs inferior to other analgesics? S Afr J AnaesthesiolAnalg16(1). • Sluka, K.A., Winter, O.C. and Wemmie, J.A. 2009. Acid-sensing ion channels: A new target for pain and CNS diseases. CurrOpin Drug DiscovDevel. 12(5):693-704. • Xiong, Z-G., Pignataro, G., Li, M., Chang, S-y and Simon, R.P. 2008. Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases. Current Opinion in Pharmacology 8:25–32.

More Related